CDC Warns of 460% Rise in Drug-Resistant 'Nightmare Bacteria' Infections
Alarming rise in drug-resistant 'nightmare bacteria' infections, with a 460% increase in NDM cases, has been reported by the CDC. These bacteria, including the flesh-eating Vibrio vulnificus, are posing serious threats along U.S. coasts and beyond.
NDM bacteria, carbapenem-resistant Enterobacterales producing the New Delhi Metallo-beta-lactamase enzyme, are behind this surge. They are resistant to most antibiotics, leaving only two expensive IV-administered options. The increase was primarily driven by bacteria carrying the NDM gene, making treatment challenging and mortality rates high.
Vibrio vulnificus, a rare but highly lethal flesh-eating bacteria, has been found in coastal waters along the East Coast and Gulf states. It thrives in warm seawater and brackish environments, posing a risk to swimmers and seafood consumers. The CDC's report highlights a drastic rise in these infections, with cases up almost 70% between 2019 and 2023. However, the true extent may be underestimated due to incomplete testing and reporting.
The CDC's findings underscore the urgent need for better surveillance, infection control, and responsible antibiotic use to combat the growing threat of drug-resistant 'nightmare bacteria'. Public awareness of risks, particularly when swimming or consuming raw seafood, is crucial. Researchers are racing to develop new treatments, but for now, prevention and careful management of existing infections are key.
Read also:
- Is it advisable to utilize your personal health insurance in a publicly-funded medical facility?
- Dietary strategies for IBS elimination: Aims and execution methods
- Benefits, suitable dosage, and safety considerations for utilizing pumpkin seed oil in treating an overactive bladder
- Harmful Medical Remedies: A Misguided Approach to Healing
